Tempest Therapeutics Inc. (TPST)
0.82
0.01 (1.31%)
At close: Mar 03, 2025, 11:54 AM
Tempest Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 295K | 653K | 277K | 9.73M | n/a | n/a | n/a |
| Cost of Revenue | 381K | 1.81M | 1.27M | 815K | 1.05M | 32K | 28K | 5.4M | 2.25M | n/a | n/a | n/a | n/a |
| Gross Profit | -381K | -1.81M | -1.27M | -815K | -1.05M | -32K | 267K | -4.75M | -1.97M | 9.73M | n/a | n/a | n/a |
| Operating Income | -29.16M | -34.64M | -26.99M | -19.3M | -45.4M | -23.12M | -20.48M | -75.61M | -72M | -47.93M | -29.13M | -13.53M | -2.62M |
| Interest Income | 1.11M | 549K | 1.28K | 90K | 264K | n/a | n/a | n/a | n/a | n/a | n/a | 19K | n/a |
| Pretax Income | -29.49M | -35.71M | -28.3M | -19.21M | -44.57M | -27.18M | -84.59M | -82.06M | -73.14M | -49.52M | -29.04M | -13.51M | -2.62M |
| Net Income | -29.49M | -36.78M | -29.55M | -19.12M | -44.57M | -27.19M | -84.58M | -82.26M | -73.22M | -49.52M | -29.04M | -13.51M | -2.73M |
| Selling & General & Admin | 11.66M | 12.11M | 9.82M | 4.91M | 16.5M | 8.66M | 5.93M | 49.22M | 51.59M | 26.15M | 13.33M | 7.21M | 1.45M |
| Research & Development | 17.5M | 22.53M | 17.17M | 14.39M | 27.84M | 14.43M | 14.53M | 21.64M | 18.43M | 21.78M | 15.8M | 6.32M | 1.17M |
| Other Expenses | n/a | 549K | -34K | n/a | n/a | n/a | 4.03M | 5.4M | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 29.16M | 34.64M | 26.99M | 19.3M | 44.35M | 23.08M | 20.45M | 70.86M | 70.03M | 47.93M | 29.13M | 13.53M | 2.62M |
| Interest Expense | 1.45M | 1.62M | 1.28M | n/a | n/a | 134K | n/a | 659K | 436K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 16.5M | -3.79M | -21.82M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 29.16M | 34.64M | 26.99M | 19.3M | 45.4M | 23.12M | 20.48M | 76.27M | 72.28M | 47.93M | 29.13M | 13.53M | 2.62M |
| Income Tax | n/a | 1.07M | 1.25M | -90K | 1K | -169K | 67K | 201K | 75K | -1.59M | 90K | n/a | n/a |
| Shares Outstanding (Basic) | 15.42M | 11.55M | 3.79M | 31.21K | 913.78K | 103.14K | 1.17K | 142.88K | 120.38K | 100.65K | 100.65K | n/a | n/a |
| Shares Outstanding (Diluted) | 15.42M | 11.55M | 3.79M | 31.21K | 913.78K | 103.14K | 1.17K | 142.88K | 120.38K | 100.65K | 100.65K | n/a | n/a |
| EPS (Basic) | -1.91 | -3.18 | -7.8 | -612.56 | -48.77 | -263.65 | -72.41K | -575.73 | -608.25 | -491.98 | -288.55 | -2.33 | n/a |
| EPS (Diluted) | -1.91 | -3.18 | -7.8 | -612.56 | -48.77 | -263.65 | -72.41K | -575.73 | -608.25 | -491.98 | -288.55 | -2.33 | n/a |
| EBITDA | -28.78M | -32.28M | -25.72M | -18.39M | -43.52M | -27.01M | -84.27M | -79.82M | -71.86M | -49.07M | -28.81M | -13.53M | -2.62M |
| Depreciation & Amortization | 381K | 1.81M | 1.27M | 815K | 1.05M | 32K | 28K | 2.24M | 1.29M | 450K | 231K | n/a | n/a |